Literature DB >> 4842252

Prognostic correlations and response to treatment in advanced metastatic malignant melanoma.

L H Einhorn, M A Burgess, C Vallejos, G P Bodey, J Gutterman, G Mavligit, E M Hersh, J K Luce, E Frei, E J Freireich, J A Gottlieb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4842252

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  30 in total

1.  Combination chemotherapy of dacarbazine and fotemustine in disseminated malignant melanoma. Experience of the French Study Group.

Authors:  M F Avril; J Bonneterre; M Delaunay; E Grosshans; P Fumoleua; L Israel; R Bugat; M Namer; D Cupissol; P Kerbrat
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Melanoma of the head and neck.

Authors:  M N Harris; D F Roses; A T Culliford; S L Gumport
Journal:  Ann Surg       Date:  1975-07       Impact factor: 12.969

3.  The prognosis of melanoma patients with metastases to two or more lymph node areas.

Authors:  R J Barth; D J Venzon; A R Baker
Journal:  Ann Surg       Date:  1991-08       Impact factor: 12.969

4.  Malignant melanoma metastasis to brain: role of degradative enzymes and responses to paracrine growth factors.

Authors:  G L Nicolson; M Nakajima; J L Herrmann; D G Menter; P G Cavanaugh; J S Park; D Marchetti
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

5.  The spectrum of small bowel melanoma.

Authors:  T A Oddson; R P Rice; H F Seigler; W M Thompson; F M Kelvin; W M Clark
Journal:  Gastrointest Radiol       Date:  1978-10-01

6.  Malignant melanoma with mesenteric metastasis causing an intrapelvic abscess: report of a case.

Authors:  T Hirota; M Kaneda; M Iwasa; H Tamaki; K Tsuneoka; S Tagawa
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

7.  Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology.

Authors:  Ozge Gumusay; Ugur Coskun; Tülay Akman; Ahmet Siyar Ekinci; Muharrem Kocar; Ozlem Balvan Erceleb; Ozan Yazıcı; Mehmet Ali Kaplan; Veli Berk; Bulent Cetin; Burcu Yapar Taskoylu; Ayhan Yildiz; Gamze Goksel; Ahmet Alacacioglu; Umut Demirci; Efnan Algin; Mukremin Uysal; Ilhan Oztop; Berna Oksuzoglu; Faysal Dane; Mahmut Gumus; Suleyman Buyukberber
Journal:  J Cancer Res Clin Oncol       Date:  2013-11-29       Impact factor: 4.553

8.  Combination chemotherapy with ifosfamide and cis-dichlorodiammineplatinum (II) in advanced malignant melanoma.

Authors:  R Becher; S Seeber; C G Schmidt
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

9.  Generation of tumor-specific cytotoxic T lymphocytes in vivo by combined treatment with inactivated tumor cells and recombinant interleukin-2.

Authors:  M Harada; G Matsuzaki; Y Shinomiya; S Kurosawa; O Ito; T Okamoto; M Takenoyama; H Sumitika; Y Nishimura; K Nomoto
Journal:  Cancer Immunol Immunother       Date:  1994-05       Impact factor: 6.968

10.  Brain surface invasion and metastasis of murine malignant melanoma variants.

Authors:  G L Nicolson; T Kawaguchi; M Kawaguchi; C Van Pelt
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.